Shareholders' Equity (Tables)

6 Months Ended

Jun. 30, 2022

Schedule of Balance Of Non-controlling Interests

The net change in the balance of our four non-controlling interests for the three and six months ended June 30, 2022 and 2021 is as follows (in thousands):


	RPSFT		Legacy Investors Partnerships		Continuing Investors Partnerships		EPA Holdings		Total
March 31, 2022	$	8,409	$	1,756,269	$	2,599,646	$	—	$	4,364,324
Contributions	—		1,425		1,456		—		2,881
Distributions	(5,754)		(103,385)		(37,828)		—		(146,967)
Other exchanges	—		—		(26,938)		—		(26,938)
Net Income	6,227		61,642		119,224		—		187,093
Other comprehensive income/(loss):
Unrealized gains on available for sale debt securities	—		1,639		2,163		—		3,802
Reclassification of unrealized gains on available for sale debt securities	—		(1,404)		(1,853)		—		(3,257)
June 30, 2022	$	8,882	$	1,716,186	$	2,655,870	$	—	$	4,380,938


	RPSFT		Legacy Investors Partnerships		Continuing Investors Partnerships		EPA Holdings		Total
December 31, 2021	$	13,528	$	1,809,269	$	2,649,154	$	—	$	4,471,951
Contributions	—		3,395		2,808		—		6,203
Distributions	(16,013)		(207,586)		(72,343)		—		(295,942)
Other exchanges	—		—		(62,222)		—		(62,222)
Net Income	11,367		112,162		139,886		—		263,415
Other comprehensive income/(loss):
Unrealized gains on available for sale debt securities	—		1,925		2,545		—		4,470
Reclassification of unrealized gains on available for sale debt securities	—		(2,979)		(3,958)		—		(6,937)
June 30, 2022	$	8,882	$	1,716,186	$	2,655,870	$	—	$	4,380,938


	RPSFT		Legacy Investors Partnerships		Continuing Investors Partnerships		EPA Holdings		Total
March 31, 2021	$	13,841	$	1,882,655	$	3,058,322	$	—	$	4,954,818
Contributions	—		6,654		4,865		—		11,519
Distributions	(12,476)		(127,747)		(30,585)		—		(170,808)
Other exchanges	—		—		(486,591)		—		(486,591)
Net income	19,275		133,743		212,961		—		365,979
Other comprehensive income/(loss):
Unrealized gains on available for sale debt securities	—		1,059		1,618		—		2,677
Reclassification of unrealized gains on available for sale debt securities	—		(2,337)		(3,571)		—		(5,908)
June 30, 2021	$	20,640	$	1,894,027	$	2,757,019	$	—	$	4,671,686


	RPSFT		Legacy Investors Partnerships		Continuing Investors Partnerships		EPA Holdings		Total
December 31, 2020	$	12,436	$	1,939,509	$	3,125,091	$	—	$	5,077,036
Contributions	—		9,907		4,865		—		14,772
Distributions	(26,129)		(222,289)		(67,768)		—		(316,186)
Other exchanges	—		—		(551,663)		—		(551,663)
Net income	34,333		170,000		251,506		—		455,839
Other comprehensive income/(loss):
Unrealized gains on available for sale debt securities	—		1,960		3,130		—		5,090
Reclassification of unrealized gains on available for sale debt securities	—		(5,060)		(8,142)		—		(13,202)
June 30, 2021	$	20,640	$	1,894,027	$	2,757,019	$	—	$	4,671,686

The Continuing Investors Partnerships’ ownership in RP Holdings decreases as the Continuing Investors Partnerships exchange RP Holdings Class B Interests held for Class A ordinary shares. As of June 30, 2022, the Continuing Investors Partnerships owned approximately 28% of RP Holdings with the remaining 72% owned by Royalty Pharma plc.